Showing 101 - 120 results of 159 for search 'Cancer well reprogramming', query time: 0.11s Refine Results
  1. 101
  2. 102
  3. 103

    Sphingosine-1-phosphate stimulates colorectal cancer tumor microenvironment angiogenesis and induces macrophage polarization via macrophage migration inhibitory factor by Fang Wu, Zhaode Feng, Xuan Wang, Yingcong Guo, Bingcong Wu, Shuheng Bai, Ning Lan, Min Chen, Juan Ren

    Published 2025-06-01
    “…BackgroundColorectal cancer (CRC) is the most common gastrointestinal malignancy with extensive reprogramming of sphingolipid metabolism. …”
    Get full text
    Article
  4. 104

    Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interacti... by Francesco Verona, Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Matilde Todaro, Giuseppe Giannini, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi

    Published 2025-02-01
    “…On the other hand, CSCs exhibited their capacity to influence immune cells, creating a favorable microenvironment for cancer progression. Interestingly, the bidirectional influence of CSCs and TME leads to an epigenetic reprogramming which sustains malignant transformation. …”
    Get full text
    Article
  5. 105

    NLRP12 decreases TRIM25-mediated HK2 degradation to promote glycolysis and H3K18la in gastric cancer by Linsen Zhou, Zhiqiang Wang, Yang Huang, Xinyi Zhang, Haohai Jiang, Zhiyuan Guo, Guangjun Zhou, Haofeng Liu

    Published 2025-08-01
    “…The present study revealed that NLRP12 was highly expressed in gastric cancer tissues and cells, as well as positively correlated with poor patient prognosis and survival. …”
    Get full text
    Article
  6. 106

    Latency, microenvironment, and the priming of a precancerous senescent cell for malignant transformation by April Kirkendoll

    Published 2025-12-01
    “…This report reexamines existing data to provide insights into the conditions necessary to prime a relatively benign and latent cell with malignant potential to respond to a stimulus and transform into cancer. I propose that normal, well-established reactions to cellular insults over time induce conditions within the affected cell which predispose it to malignant transformation. …”
    Get full text
    Article
  7. 107

    Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy by Qian Zeng, Min Liu, Ziqi Wang, Rongrong Zhou, Kelong Ai

    Published 2025-06-01
    “…Abstract Radiotherapy (RT) remains a cornerstone treatment for over 50% of cancer patients, primarily via ionizing radiation-induced DNA damage to exert therapeutic effects. …”
    Get full text
    Article
  8. 108

    Aristolochic acid I orchestrates multi-organ carcinogenesis through apoptotic pathway in bladder, kidney, and liver cancers: a multi-omics dissection by Bitian Zhang, Ping-Chung Leung, Chun-Kwok Wong, Dongjie Wang

    Published 2025-06-01
    “…Abstract Aristolochic acid I (AA-I), a naturally occurring compound derived from plants of the genus Aristolochia, is a well-documented nephrotoxin and carcinogen linked to bladder (BLCA), kidney (KIRC), and liver (LIHC) cancers. …”
    Get full text
    Article
  9. 109

    Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity by Steven Brem

    Published 2024-12-01
    “…Immuno-oncology, specifically immune checkpoint inhibitors (ICIs), has revolutionized cancer care with dramatic, long-term responses and increased survival, including patients with metastatic cancer to the brain. …”
    Get full text
    Article
  10. 110

    Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis by Ruining Gong, Ying Chen, Chang Li, Huan Zhang, Zimin Liu, Qian Yu

    Published 2025-05-01
    “…Checkpoint-based immunotherapy has largely been ineffective for most pancreatic cancer patients. This ineffectiveness is not well understood, as clinical trials often involve patients with advanced diseases, such as liver and peritoneal metastases, while most preclinical studies focus on primary tumors. …”
    Get full text
    Article
  11. 111

    DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway by Hui Wang, Shen Luo, Yue Yin, Yang Liu, Xiaomei Sun, Ling Qiu, Xin Wu

    Published 2025-01-01
    “…Abstract Background Ovarian cancer (OC) remains a lethal gynecological malignancy with an alarming mortality rate, primarily attributed to delayed diagnosis and a lack of effective treatment modalities. …”
    Get full text
    Article
  12. 112
  13. 113

    Single-Cell and Single-Nuclei transcriptomics profiling reveals dynamic cellular features in tumor-related adipose microenvironment of breast cancer patients with high BMI by Xiaoxiao Hu, Fang Jia, Lili Li, Wuzhen Chen, Leyi Zhang, Jun Pan, Sangsang Zhu, Zhen Wang, Jian Huang

    Published 2025-07-01
    “…Objectives: High body mass index (BMI), encompassing overweight and obesity, is a well-established risk factor for developing breast cancer (BC). …”
    Get full text
    Article
  14. 114

    Immunocytes in the tumor microenvironment: recent updates and interconnections by Jiyao Yu, Jiyao Yu, Li Fu, Li Fu, Rui Wu, Rui Wu, Linyi Che, Linyi Che, Guodong Liu, Qinwen Ran, Zhiwei Xia, Xisong Liang, Xisong Liang, Guanjian Zhao

    Published 2025-04-01
    “…By integrating recent molecular insights and clinical advancements, the review underscores the importance of deciphering the interplay between immunocytes and the TME to develop more effective cancer immunotherapies.…”
    Get full text
    Article
  15. 115

    Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling by Jinhui Ye, Song Wu, Qiang Quan, Feng Ye, Jinhui Zhang, Cailu Song, Yidan Fan, Huijiao Cao, Hailin Tang, Jianfu Zhao

    Published 2024-12-01
    “…Additionally, Oil Red O staining, fatty acid metabolite detection, and Western blot analysis were used to investigate the impact of FGFR4 and its inhibitor fisogatinib, as well as the AKT activator SC79, on the metabolic reprogramming of fatty acids in TNBC cells. …”
    Get full text
    Article
  16. 116

    FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma by Yuan Hepei, Zeng Jun, Khan Muhammad, Wang Baiyao, Hu Xiaoshan, Wei Hao, Wang Zhaotong, Yuan Yawei

    Published 2025-07-01
    “…Abstract Background Colorectal cancer progression and immune evasion are closely linked to mitochondrial and peroxisomal metabolic reprogramming, yet the role of peroxisomes remains underexplored. …”
    Get full text
    Article
  17. 117

    Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma by Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano, Takumi Kawaguchi

    Published 2025-03-01
    “…Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer deaths worldwide. …”
    Get full text
    Article
  18. 118
  19. 119

    Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Hu... by Tiegang Li, Zheng Yan, Mingxuan Zhou, Wenyi Zhao, Fang Zhang, Silin Lv, Yufang Hou, Zifan Zeng, Liu Yang, Yixin Zhou, Zengni Zhu, Xinyi Ren, Min Yang

    Published 2025-07-01
    “…<b>Background:</b> Huang Qin Decoction (HQD) is a well-established Traditional Chinese Medicine (TCM) formulation recognized for its application in the treatment of colorectal cancer (CRC). …”
    Get full text
    Article
  20. 120

    Integrated transcriptomics and machine learning reveal REN as a dual regulator of tumor stemness and NK cell evasion in Wilms tumor progression by Qingfei Cao, Junyi Li, Yunfei Zou, Changwen Xu, Huihui Tang, Meixue Chen

    Published 2025-06-01
    “…IntroductionWilms tumor (WT) is the most common pediatric kidney cancer, which presents significant therapeutic challenges, particularly in high-risk cases, due to chemotherapy resistance and immunosuppressive tumor microenvironments (TMEs). …”
    Get full text
    Article